Cytochrome P450 2c9 phenotyping using low-dose tolbutamide
- Author
- JETTER, Alexander1 ; KINZIG-SCHIPPERS, Martina2 ; JABRANE, Wafaa1 ; KASEL, Dirk1 ; BROCKMÖLLER, Jürgen4 ; FUHR, Uwe1 ; SÖRGEL, Fritz2 ; SKOTT, Andreas2 ; LAZAR, Andreas1 ; TOMALIK-SCHARTE, Dorota1 ; KIRCHHEINER, Julia3 ; WALCHNER-BONJEAN, Monika1 ; HERING, Ursula1 ; JAKOB, Verena2 ; RODAMER, Michael2
[1] Department of Pharmacology, Clinical Pharmacology, University of Cologne, Gleueler Strasse 24, 50931 Köln, Germany
[2] Institute for Biomedical and Pharmaceutical Research, Nürnberg-Heroldsberg, Germany
[3] Institute of Clinical Pharmacology, University Medical Centre Charité, Humboldt University, Berlin, Germany
[4] Department of Clinical Pharmacology, Georg-August University, Göttingen, Germany - Source
European journal of clinical pharmacology. 2004, Vol 60, Num 3, pp 165-171, 7 p ; ref : 16 ref
- ISSN
- 0031-6970
- Scientific domain
- Pharmacology drugs
- Publisher
- Springer, Berlin
/
Springer, Heidelberg
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Cytochrome P450 2C9 Phenotyping Tolbutamide
- Keyword (fr)
- Cytochrome P450 Dose faible Homme Hypoglycémiant Isozyme Tolbutamide Enzyme Sulfonylurées
- Keyword (en)
- Cytochrome P450 Low dose Human Hypoglycemic agent Isozyme Tolbutamide Enzyme Sulfonylureas
- Keyword (es)
- Citocromo P450 Dosis débil Hombre Hipoglicemiante Isozima Tolbutamida Enzima Sulfonilureas
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Discipline
- General pharmacology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15773510
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s00228-004-0754-z 
https://dx.doi.org/10.1007/s00228-004-0754-z
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00228-004-0754-z\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:9:\"\u0000*\u0000jtitle\";s:41:\"European journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Eur. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0031-6970\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"JETTER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:25:\"KINZIG-SCHIPPERS, Martina\";i:1;s:14:\"JABRANE, Wafaa\";i:2;s:11:\"KASEL, Dirk\";i:3;s:21:\"BROCKM\u00d6LLER, J\u00fcrgen\";i:4;s:9:\"FUHR, Uwe\";i:5;s:14:\"S\u00d6RGEL, Fritz\";i:6;s:14:\"SKOTT, Andreas\";i:7;s:14:\"LAZAR, Andreas\";i:8;s:23:\"TOMALIK-SCHARTE, Dorota\";i:9;s:18:\"KIRCHHEINER, Julia\";i:10;s:24:\"WALCHNER-BONJEAN, Monika\";i:11;s:14:\"HERING, Ursula\";i:12;s:13:\"JAKOB, Verena\";i:13;s:16:\"RODAMER, Michael\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00228-004-0754-z\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:9:\"\u0000*\u0000jtitle\";s:41:\"European journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Eur. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0031-6970\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"JETTER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:25:\"KINZIG-SCHIPPERS, Martina\";i:1;s:14:\"JABRANE, Wafaa\";i:2;s:11:\"KASEL, Dirk\";i:3;s:21:\"BROCKM\u00d6LLER, J\u00fcrgen\";i:4;s:9:\"FUHR, Uwe\";i:5;s:14:\"S\u00d6RGEL, Fritz\";i:6;s:14:\"SKOTT, Andreas\";i:7;s:14:\"LAZAR, Andreas\";i:8;s:23:\"TOMALIK-SCHARTE, Dorota\";i:9;s:18:\"KIRCHHEINER, Julia\";i:10;s:24:\"WALCHNER-BONJEAN, Monika\";i:11;s:14:\"HERING, Ursula\";i:12;s:13:\"JAKOB, Verena\";i:13;s:16:\"RODAMER, Michael\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00228-004-0754-z\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00228-004-0754-z\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:9:\"\u0000*\u0000jtitle\";s:41:\"European journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Eur. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0031-6970\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"JETTER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:25:\"KINZIG-SCHIPPERS, Martina\";i:1;s:14:\"JABRANE, Wafaa\";i:2;s:11:\"KASEL, Dirk\";i:3;s:21:\"BROCKM\u00d6LLER, J\u00fcrgen\";i:4;s:9:\"FUHR, Uwe\";i:5;s:14:\"S\u00d6RGEL, Fritz\";i:6;s:14:\"SKOTT, Andreas\";i:7;s:14:\"LAZAR, Andreas\";i:8;s:23:\"TOMALIK-SCHARTE, Dorota\";i:9;s:18:\"KIRCHHEINER, Julia\";i:10;s:24:\"WALCHNER-BONJEAN, Monika\";i:11;s:14:\"HERING, Ursula\";i:12;s:13:\"JAKOB, Verena\";i:13;s:16:\"RODAMER, Michael\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00228-004-0754-z\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:9:\"\u0000*\u0000jtitle\";s:41:\"European journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Eur. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0031-6970\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"JETTER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:25:\"KINZIG-SCHIPPERS, Martina\";i:1;s:14:\"JABRANE, Wafaa\";i:2;s:11:\"KASEL, Dirk\";i:3;s:21:\"BROCKM\u00d6LLER, J\u00fcrgen\";i:4;s:9:\"FUHR, Uwe\";i:5;s:14:\"S\u00d6RGEL, Fritz\";i:6;s:14:\"SKOTT, Andreas\";i:7;s:14:\"LAZAR, Andreas\";i:8;s:23:\"TOMALIK-SCHARTE, Dorota\";i:9;s:18:\"KIRCHHEINER, Julia\";i:10;s:24:\"WALCHNER-BONJEAN, Monika\";i:11;s:14:\"HERING, Ursula\";i:12;s:13:\"JAKOB, Verena\";i:13;s:16:\"RODAMER, Michael\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00228-004-0754-z\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:9:\"\u0000*\u0000jtitle\";s:41:\"European journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Eur. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0031-6970\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"JETTER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Alexander\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:25:\"KINZIG-SCHIPPERS, Martina\";i:1;s:14:\"JABRANE, Wafaa\";i:2;s:11:\"KASEL, Dirk\";i:3;s:21:\"BROCKM\u00d6LLER, J\u00fcrgen\";i:4;s:9:\"FUHR, Uwe\";i:5;s:14:\"S\u00d6RGEL, Fritz\";i:6;s:14:\"SKOTT, Andreas\";i:7;s:14:\"LAZAR, Andreas\";i:8;s:23:\"TOMALIK-SCHARTE, Dorota\";i:9;s:18:\"KIRCHHEINER, Julia\";i:10;s:24:\"WALCHNER-BONJEAN, Monika\";i:11;s:14:\"HERING, Ursula\";i:12;s:13:\"JAKOB, Verena\";i:13;s:16:\"RODAMER, Michael\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Cytochrome P450 2c9 phenotyping using low-dose tolbutamide\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
